Transaction Readiness & M&A Advisory for Biotech Companies
Your challenge
You are preparing for a financing round, a strategic partnership, or a potential exit.
The question is not only whether to transact, but how to position your company to attract the right investors or buyers, stand out in a crowded market, and ultimately maximize valuation.
Our solution
Betta Scientific supports biotech companies in becoming transaction-ready and strategically compelling. We help sharpen your equity story, clarify value drivers, and prepare you for complex financing or M&A processes with a clear, professional, and credible positioning. Leveraging deep experience in biotech transactions, we guide you through critical decision points to achieve optimal outcomes.
What you get
-
Clear investor and buyer positioning aligned with your strategic objectives
-
Comprehensive transaction and exit readiness preparation
-
Strategic M&A advisory and hands-on execution support
Your project, step-by-step
Understand your transaction objectives
-
We assist you in defining your financing, partnership, or exit goals
-
We analyze your business model, pipeline, and core value drivers
-
We assess transaction readiness to identify gaps and priorities
Prepare for the transaction
-
We sharpen your strategic narrative and investor positioning
-
We prepare transaction materials and key messages
-
We define the optimal transaction structure and timeline
Support the transaction process
-
We support interactions with investors and buyers
-
We assist in due diligence preparation and coordination
-
We provide strategic guidance throughout negotiations
Deliverables
-
Investor and transaction positioning strategy
-
Transaction readiness assessment and action plan
-
Strategic M&A and transaction support